Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Cyclin-dependent kinase 4 (CDK4) messenger RNA 3' untranslated region (3'-UTR) is a vital regulatory sequence located immediately downstream of the protein-coding region. It serves as a primary site for post-transcriptional regulation, containing multiple binding motifs for microRNAs (miRNAs) such as miR-124, miR-34a, and miR-200c, which negatively regulate CDK4 expression (PubMed: 24607534, 18364343). Because CDK4 is a central mediator of the G1/S phase transition in the cell cycle, its overexpression is a common driver in various cancers. This overexpression is often facilitated by the loss of miRNA-mediated control at the 3'-UTR or specific genetic variations within the region. Therapeutic approaches targeting this region involve the use of miRNA mimics or antisense oligonucleotides (ASOs) to suppress CDK4 protein production at the source. This target is particularly significant in precision oncology, where polymorphisms in the 3'-UTR, such as rs14734, can serve as biomarkers for disease susceptibility or treatment response (PubMed: 25663388). Unlike traditional small-molecule inhibitors that target the CDK4 protein, targeting the 3'-UTR aims to reduce the total abundance of the oncogenic protein through mRNA degradation or translational blockade.
Post-transcriptional gene silencing via microRNA-mediated mRNA degradation or translational inhibition.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cyclin-dependent kinase 4 messenger RNA 3' untranslated region (CDK4 mRNA 3'-UTR).